Echo Biotech
Latest round
- Series B
Last raised
- Nov 2025
Total raised
- $30M
Investors
- 8
About Echo Biotech
Established in 2017 and headquartered in Beijing, China, Echo Biotech engages in exosome research, clinical transformation and regenerative medicine development. The company collaborates with more than 100 hospitals across China and has jointly published over 100 peer-reviewed papers, including more than 60 exosome-related research articles. Echo Biotech holds over 10 patents related to exosome technology and has built a comprehensive R&D and GMP production system. The company's main business is divided into two parts: one is the research and development of innovative drugs based on exosomes, which mainly cover the fields of tumor immunity, rare diseases and neurological diseases. The second is translational medicine research services based on exosomes, including body fluid exosomes, tissue exosomes, exosomal functions, and single-cell joint tissue exosomes overall solutions, mainly in cooperation with clinical experts to carry out scientific research. The company generates revenue through R&D collaboration agreements, licensing of exosome technologies and the provision of translational medicine research services to hospitals, universities, and pharmaceutical partners.
Who invested in Echo Biotech
8 investors across 5 rounds
See all investors in Echo Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Echo Biotech
Who invested in Echo Biotech?
Echo Biotech has 8 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Echo Biotech raised?
Echo Biotech has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Echo Biotech last raise money?
Echo Biotech's most recent round on record is a Series B, in Nov 2025.
What does Echo Biotech do?
Established in 2017 and headquartered in Beijing, China, Echo Biotech engages in exosome research, clinical transformation and regenerative medicine development.
Where is Echo Biotech headquartered?
Echo Biotech is headquartered in Beijing, China.
Which VCs invest in companies like Echo Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Echo Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Echo Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.